First-in-Human Heart Pump Implant Study
Part of Heart & circulation clinical trials.
This trial tests a new tiny heart pump called the Icoms Flowmaker for patients with severe heart failure who cannot have a standard heart pump. The device may help your heart pump blood better and improve your ability to do daily activities.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age 18–80 years old
- Severe heart failure (ejection fraction ≤35%) that hasn't improved with medicines
- Your heart is enlarged enough for the pump (specific measurements required)
- You have a contraindication to standard heart pumps OR high risk from the driveline (the tube connecting the pump to the outside), OR you're waiting for a heart transplant but temporarily cannot have one
- You do not have active infections, blood clots, or severe lung, liver, or kidney disease
- You live with someone who can help care for you after implant
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
This trial tests a temporary heart pump to support patients with weak hearts (ejection fraction 35% or less) who need a high-risk stent procedure instead of bypass surgery. The pump may help keep blood flowing during the procedure.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This trial studies whether putting in a small heart pump early (through the leg) helps people with a heart attack complicated by severe heart weakness (“cardiogenic shock”) compared with standard treatment. It aims to improve survival and recovery by supporting blood flow sooner.
Hear when a new Advanced Heart Failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.